In the current issue:
-
The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseases
Rušinová Lenka et al. -
Analysis of metalothionein in patients with malignant liver tumors
Melich Luděk et al. -
Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease
Matsumoto Hiroaki et al.
Reviews
Klin Onkol 2024; 37(5): 324-330.
DOI: 10.48095/ccko2024324.
Keywords: breast cancer – cardiovascular disease – dyslipidemia – chemotherapy
Authors: Rušinová Lenka, Kozárová Miriam, Bavoľárová – Valíková Marcela2024-10-15:The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseases
Keywords: breast cancer – cardiovascular disease – dyslipidemia – chemotherapy
Authors: Rušinová Lenka, Kozárová Miriam, Bavoľárová – Valíková Marcela2024-10-15:The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseases
Klin Onkol 2024; 37(5): 331-334.
DOI: 10.48095/ccko2024331.
Keywords: pancreatic cancer – gemcitabine/nab-paclitaxel – FOLFIRINOX – GENERATE study – nanoliposomal irinotecan
Authors: Tomášek Jiří2024-10-15:Gemcitabine/nab-paclitaxel in first line treatment of advanced pancreatic cancer – head-to-head comparison with the mFOLFIRINOX regimen
Keywords: pancreatic cancer – gemcitabine/nab-paclitaxel – FOLFIRINOX – GENERATE study – nanoliposomal irinotecan
Authors: Tomášek Jiří2024-10-15:Gemcitabine/nab-paclitaxel in first line treatment of advanced pancreatic cancer – head-to-head comparison with the mFOLFIRINOX regimen
Original articles
Klin Onkol 2024; 37(5): 335-344.
DOI: 10.48095/ccko2024335.
Keywords: anal cancer – radiotherapy – concurrent chemoradiotherapy – side effects – treatment effectiveness
Authors: Pechačová Zdeňka, Lohynská Radka, Šantrůčková Šárka, Šubrt Adam, Drbohlavová Tereza, Pála Miloslav2024-10-15:Accelerated radiotherapy in the treatment of anal squamous cell carcinoma – a single institution retrospective evaluation
Keywords: anal cancer – radiotherapy – concurrent chemoradiotherapy – side effects – treatment effectiveness
Authors: Pechačová Zdeňka, Lohynská Radka, Šantrůčková Šárka, Šubrt Adam, Drbohlavová Tereza, Pála Miloslav2024-10-15:Accelerated radiotherapy in the treatment of anal squamous cell carcinoma – a single institution retrospective evaluation
Klin Onkol 2024; 37(5): 345-353.
DOI: 10.48095/ccko2024345.
Keywords: targeted therapy – cancer – malignant tumor – nanomedicine – Brdička’s reaction
Authors: Melich Luděk, Werle Julia, Fořtová Magda , Vysloužilová. Lenka, Burešová Kristýna, Kotaška Karel, Klapková Eva, Štěpánková Olga, Čepová Jana, Průša Richard, Kizek René2024-10-15:Analysis of metalothionein in patients with malignant liver tumors
Keywords: targeted therapy – cancer – malignant tumor – nanomedicine – Brdička’s reaction
Authors: Melich Luděk, Werle Julia, Fořtová Magda , Vysloužilová. Lenka, Burešová Kristýna, Kotaška Karel, Klapková Eva, Štěpánková Olga, Čepová Jana, Průša Richard, Kizek René2024-10-15:Analysis of metalothionein in patients with malignant liver tumors
Case report
Klin Onkol 2024; 37(5): 354-369.
DOI: 10.48095/ccko2024354.
Keywords: retroperitoneal fibrosis – IgG4-related disease – rituximab – cyclophosphamide – circulating plasmablasts
Authors: Čermák Aleš, Foukal Jakub, Řehák Zdeněk, Adam Zdeněk, Keřkovský Miloš, Hruška Lukáš, Borský Marek, Doubek Michael, Vlažný Jakub, Pavlovský Zdeněk, Chovancová Zita, Boichuk Ivanna, Štork Martin, Pour Luděk, Koukalová Renata, Tomíška Miroslav, Král Zdeněk2024-10-15:Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone,
Keywords: retroperitoneal fibrosis – IgG4-related disease – rituximab – cyclophosphamide – circulating plasmablasts
Authors: Čermák Aleš, Foukal Jakub, Řehák Zdeněk, Adam Zdeněk, Keřkovský Miloš, Hruška Lukáš, Borský Marek, Doubek Michael, Vlažný Jakub, Pavlovský Zdeněk, Chovancová Zita, Boichuk Ivanna, Štork Martin, Pour Luděk, Koukalová Renata, Tomíška Miroslav, Král Zdeněk2024-10-15:Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone,
Klin Onkol 2024; 37(5): 370-374.
DOI: 10.48095/ccko2024370.
Keywords: rectal cancer – total neoadjuvant therapy – immunotherapy – checkpoint inhibitors – microsatellite instability (MSI) – deficient mismatch repair (dMMR)
Authors: Křivonosková Soňa, Opluštilová Anna, Levý Miroslav, Komár Martin, Rosová Blanka, Lohynská Radka, Boublíková Ludmila2024-10-15:Total neoadjuvant therapy involving checkpoint inhibitors in locally advanced MSI/dMMR rectal cancer – a case report
Keywords: rectal cancer – total neoadjuvant therapy – immunotherapy – checkpoint inhibitors – microsatellite instability (MSI) – deficient mismatch repair (dMMR)
Authors: Křivonosková Soňa, Opluštilová Anna, Levý Miroslav, Komár Martin, Rosová Blanka, Lohynská Radka, Boublíková Ludmila2024-10-15:Total neoadjuvant therapy involving checkpoint inhibitors in locally advanced MSI/dMMR rectal cancer – a case report
Klin Onkol 2024; 37(5): 375-379.
DOI: 10.48095/ccko2024375.
Keywords: checkpoint inhibitor – chronické onemocnění ledvin – karcinom plic – dlaždicobuněčný karcinom
Authors: Matsumoto Hiroaki, Maezawa Yosuke, Ohara Gen, Shiozawa Toshihiro, Masuko Hironori, Satoh Hiroaki2024-10-15:Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease
Keywords: checkpoint inhibitor – chronické onemocnění ledvin – karcinom plic – dlaždicobuněčný karcinom
Authors: Matsumoto Hiroaki, Maezawa Yosuke, Ohara Gen, Shiozawa Toshihiro, Masuko Hironori, Satoh Hiroaki2024-10-15:Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease
Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Klin Onkol 2024; 37(5): 380-383.
DOI: 10.48095/ccko2024380.
Keywords: checkpoint inhibitors – pembrolizumab – drug side effects – pneumonitis – non-small cell lung carcinoma
Authors: Podhorec Ján, Jakubíková Lenka, Bílek Ondřej, Kiss Igor, Poprach Alexandr2024-10-15:Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Keywords: checkpoint inhibitors – pembrolizumab – drug side effects – pneumonitis – non-small cell lung carcinoma
Authors: Podhorec Ján, Jakubíková Lenka, Bílek Ondřej, Kiss Igor, Poprach Alexandr2024-10-15:Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Short Communications
Klin Onkol 2024; 37(5): 384-389.
DOI: 10.48095/ccko2024384.
Keywords: MLH1 – MSH2/EPCAM – MSH6 – PMS2 – consensus – guidelines for clinical practice – germline mutation carriers
Authors: Novotný Jan, Cibula David, Curtisová Václava, Dubová Oľga, Foretová Lenka, Germanová Anna , Janatová Markéta, Havránek Ondřej, Hojsáková Markéta, Hudcová Markéta, Koudová Monika, Krutílková Věra, Palácová Markéta, Paulich Sviatlana , Petráková Katarína, Presl Jiří, Puchmajerová Alena, Soukupová Jana, Šenkeříková Mária, Šimková Zuzana, Štěpánková Helena, Šubrt Ivan, Tachecí Ilja, Tesner Pavel, Urban Ondřej, Veselá Kamila, Vilímová Šárka, Vlčková Zdeňka, Vočka Michal, Weinberger Vít, Zikán Michal, Zimovjanová Martina, Kleibl Zdeněk, Kleiblová Petra2024-10-15:The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)
Keywords: MLH1 – MSH2/EPCAM – MSH6 – PMS2 – consensus – guidelines for clinical practice – germline mutation carriers
Authors: Novotný Jan, Cibula David, Curtisová Václava, Dubová Oľga, Foretová Lenka, Germanová Anna , Janatová Markéta, Havránek Ondřej, Hojsáková Markéta, Hudcová Markéta, Koudová Monika, Krutílková Věra, Palácová Markéta, Paulich Sviatlana , Petráková Katarína, Presl Jiří, Puchmajerová Alena, Soukupová Jana, Šenkeříková Mária, Šimková Zuzana, Štěpánková Helena, Šubrt Ivan, Tachecí Ilja, Tesner Pavel, Urban Ondřej, Veselá Kamila, Vilímová Šárka, Vlčková Zdeňka, Vočka Michal, Weinberger Vít, Zikán Michal, Zimovjanová Martina, Kleibl Zdeněk, Kleiblová Petra2024-10-15:The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)
